| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 35,965 | 2,048 |
| Net increase (decrease) in cash, cash equivalents and restricted cash equivalents | 14,814 | -13,452 |
| Cash and cash equivalents at beginning of period | 25,009 | - |
| Cash and cash equivalents at end of period | 39,823 | - |
COGNITION THERAPEUTICS INC (CGTX)
COGNITION THERAPEUTICS INC (CGTX)